TOR1A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.401200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.178800E-01
Normal-vs-Stage2
9.036400E-01
Normal-vs-Stage3
4.171400E-01
Normal-vs-Stage4
6.552600E-01
Stage1-vs-Stage2
4.266800E-01
Stage1-vs-Stage3
5.994200E-01
Stage1-vs-Stage4
3.296600E-01
Stage2-vs-Stage3
2.208000E-01
Stage2-vs-Stage4
6.626800E-01
Stage3-vs-Stage4
2.511200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.649400E-01
Normal-vs-AfricanAmerican
9.214800E-01
Normal-vs-Asian
6.056400E-01
Caucasian-vs-AfricanAmerican
9.434200E-01
Caucasian-vs-Asian
3.849200E-01
AfricanAmerican-vs-Asian
6.048600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.235600E-01
Normal-vs-Female
7.377600E-01
Male-vs-Female
3.797800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.974000E-01
Normal-vs-Age(41-60Yrs)
3.866200E-01
Normal-vs-Age(61-80Yrs)
8.944400E-01
Normal-vs-Age(81-100Yrs)
6.785600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.392800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.765600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.808600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.018700E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.993500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.357600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.530000E-01
Normal-vs-Daily Drinker
7.981600E-01
Normal-vs-Weekly Drinker
7.412200E-01
Normal-vs-Occasional Drinker
5.240400E-01
Normal-vs-Social Drinker
4.751800E-01
Non Drinker-vs-Daily Drinker
6.087000E-01
Non Drinker-vs-Weekly Drinker
1.490190E-01
Non Drinker-vs-Occasional Drinker
3.060500E-02
Non Drinker-vs-Social Drinker
2.200200E-02
Daily Drinker-vs-Weekly Drinker
2.811200E-01
Daily Drinker-vs-Occasional Drinker
7.775900E-02
Daily Drinker-vs-Social Drinker
5.454100E-02
Weekly Drinker-vs-Occasional Drinker
6.368000E-01
Weekly Drinker-vs-Social Drinker
4.704800E-01
Occasional Drinker-vs-Social Drinker
7.304000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.153800E-01
Normal-vs-Grade 2
9.018600E-01
Normal-vs-Grade 3
9.139000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.424200E-01
Grade 1-vs-Grade 3
9.865000E-01
Grade 1-vs-Grade 4
9.153800E-01
Grade 2-vs-Grade 3
7.643000E-01
Grade 2-vs-Grade 4
9.018600E-01
Grade 3-vs-Grade 4
9.139000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.377000E-01
Normal-vs-NonDiabetic
7.702800E-01
Diabetic-vs-NonDiabetic
1.247770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.592400E-01
Normal-vs-NoPancreatitis
8.197600E-01
Pancreatitis-vs-NoPancreatitis
5.975400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.526400E-01
Normal-vs-N1
9.077200E-01
N0-vs-N1
3.964400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.404400E-01
Normal-vs-TP53-NonMutant
9.277400E-01
TP53-Mutant-vs-TP53-NonMutant
9.398200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
